Olema Pharmaceuticals, Inc. Insider Transactions
Olema Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Harmon Cyrus
Director |
Sell | 25,000 @ $12.57 | $314,250 | 926,283 | 11/30/2023 | 12/01/2023 | |
|
Harmon Cyrus
Director |
Sell | 3,989 @ $13.90 | $55,447 | 951,283 | 11/22/2023 | 11/22/2023 | |
|
Zojwalla Naseem
CHIEF MEDICAL OFFICER |
Sell | 7,095 @ $13.89 | $98,550 | 30,664 | 11/22/2023 | 11/22/2023 | |
|
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF |
Sell | 6,653 @ $13.89 | $92,410 | 574,099 | 11/22/2023 | 11/22/2023 | |
|
Bohen Sean
CEO |
Sell | 27,932 @ $13.90 | $388,255 | 144,925 | 11/22/2023 | 11/22/2023 | |
|
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF. |
Sell | 9,145 @ $13.89 | $127,024 | 424,987 | 11/22/2023 | 11/22/2023 | |
|
Harmon Cyrus
Director |
Sell | 4,192 @ $14.86 | $62,293 | 955,272 | 11/21/2023 | 11/22/2023 | |
|
Zojwalla Naseem
CHIEF MEDICAL OFFICER |
Sell | 7,261 @ $14.83 | $107,681 | 37,959 | 11/21/2023 | 11/22/2023 | |
|
Zojwalla Naseem
CHIEF MEDICAL OFFICER |
Sell | 200 @ $15.33 | $3,066 | 37,759 | 11/21/2023 | 11/22/2023 | |
|
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF |
Sell | 6,776 @ $14.87 | $100,759 | 580,952 | 11/21/2023 | 11/22/2023 | |
|
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF |
Sell | 200 @ $15.32 | $3,064 | 580,752 | 11/21/2023 | 11/22/2023 | |
|
Bohen Sean
CEO |
Sell | 26,691 @ $14.84 | $396,094 | 175,459 | 11/21/2023 | 11/22/2023 | |
|
Bohen Sean
CEO |
Sell | 2,602 @ $15.29 | $39,785 | 172,857 | 11/21/2023 | 11/22/2023 | |
|
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF. |
Sell | 8,897 @ $14.83 | $131,943 | 434,832 | 11/21/2023 | 11/22/2023 | |
|
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF. |
Sell | 700 @ $15.27 | $10,689 | 434,132 | 11/21/2023 | 11/22/2023 | |
|
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF |
Sell | 200 @ $17.61 | $3,522 | 561,270 | 11/08/2023 | 11/13/2023 | |
|
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF |
Sell | 541 @ $17.51 | $9,473 | 561,470 | 11/03/2023 | 11/03/2023 | |
|
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF |
Sell | 3,332 @ $15.36 | $51,180 | 562,011 | 11/02/2023 | 11/03/2023 | |
|
Harmon Cyrus
Director |
Sell | 5,000 @ $15.64 | $78,200 | 943,714 | 11/02/2023 | 11/02/2023 | |
|
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF |
Sell | 6,668 @ $15.02 | $100,153 | 565,343 | 11/01/2023 | 11/03/2023 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Olema Pharmaceuticals, Inc. FAQ's
The list of insiders at Olema Pharmaceuticals, Inc. includes Harmon Cyrus, Graham G. Walmsley, Paradigm Biocapital Advisors LP, Bohen Sean, Kovacs Shane William Charles, Zojwalla Naseem, Myles David C..
Insiders have sold a total of 5.29 M Olema Pharmaceuticals, Inc. shares in the last 12 months for a total of 65.67 M sold.
The following insiders have sold Olema Pharmaceuticals, Inc. shares in the last 12 months: Harmon Cyrus ($1.18 M), Graham G. Walmsley ($26.91 M), Paradigm Biocapital Advisors LP ($35.80 M), Bohen Sean ($986,365), Kovacs Shane William Charles ($316,703), Zojwalla Naseem ($250,456), Myles David C. ($234,916),